Effect of inhaled ciclesonide in adult patients with asthma (BY9010/M1-125)

Exclusion Criteria

• - Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids (e.g. lung tuberculosis)
• - Clinically relevant abnormal laboratory values suggesting an unknown disease and requiring further clinical evaluation
• - Use of systemic steroids 4 weeks (injectable depot steroids 6 weeks) before entry into the baseline period, or more than 3 times during the last 6 months
• - Pregnancy or intention to become pregnant during the course of the study, breast feeding, lack of safe contraception in heterosexually active female patients of child-bearing potential, or postmenopausal for less than one year
• - COPD (i.e. chronic bronchitis or emphysema) and/or other relevant lung diseases
• - Known or suspected hypersensitivity to inhaled steroids or to the other excipients of the metered dose inhalers
• - Immunotherapy within one month prior to B0 and/or during the entire study duration